Author Topic: Pro and con about whether rituximab is an acceptable alternative to ocrelizumab  (Read 51 times)

0 Members and 0 Guests are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 8247
  • MS diagnosed 1980
  • Location: Pacific Northwest
Multiple Sclerosis Journal often publishes a "yes" and "no" side to a debate, accompanied by a commentary. The August issue's debate topic is whether rituximab is an acceptable alternative to ocrelizumab in treating MS.


The "Yes" side:


http://journals.sagepub.com/doi/full/10.1177/1352458518757930


The "No" side:


http://journals.sagepub.com/doi/full/10.1177/1352458518757931


And the Commentary:


http://journals.sagepub.com/doi/full/10.1177/1352458518760717
« Last Edit: August 04, 2018, 11:26:41 am by agate »
MS Speaks--online for 13 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010.

 

Related Topics

  Subject / Started by Replies Last post
0 Replies
71 Views
Last post March 14, 2016, 12:22:55 pm
by agate
0 Replies
110 Views
Last post September 18, 2016, 11:08:16 am
by agate
2 Replies
211 Views
Last post December 26, 2016, 02:47:31 pm
by agate
0 Replies
60 Views
Last post February 12, 2018, 04:07:56 pm
by agate
0 Replies
38 Views
Last post May 04, 2018, 02:21:14 pm
by agate